Trials / Completed
CompletedNCT07063706
Pharmaceutical Care for Patients Using Capecitabine
Impact of Pharmaceutical Care on Patients Using Capecitabine: a Multicenter Randomized Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 176 (actual)
- Sponsor
- Faculdade de Farmácia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a longitudinal, prospective and intervention study, which will be carried out with patients undergoing treatment with capecitabine, where the impact of pharmaceutical care will be evaluated.
Detailed description
Pharmaceutical care (PC) is a professional service in which the pharmacist, actively and in direct interaction with the patient, seeks to achieve concrete health results through the use of medications that improve their quality of life, considering their socioeconomic and cultural context. Through the practice of PC, it becomes possible to detect drug-related problems (DRPs), in addition to the possibility of preventing and resolving negative outcomes associated with the drug (NMR). With recent advances in cancer treatment, the increasing use of oral antineoplastic agents has accelerated. Despite the advantages involved in the use of oral chemotherapy compared to intravenous chemotherapy, there are associated risks that can compromise patient safety and the effectiveness of anticancer therapy. PC as a strategy to ensure and promote the safe and rational use of oral antineoplastics has been increasingly used in the care of cancer patients. This is a longitudinal, prospective, interventional study that will be conducted with patients undergoing treatment with capecitabine. The study will last 30 months, from March 1, 2022 to August 30, 2024. The study will be conducted in two reference centers for oncology treatment in the city of Rio de Janeiro.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pharmaceutical Care | Participants in the intervention group received pharmaceutical care |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2024-03-31
- Completion
- 2024-08-30
- First posted
- 2025-07-14
- Last updated
- 2025-07-18
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT07063706. Inclusion in this directory is not an endorsement.